publication date: Oct. 13, 2017

In Brief

Carl June, Sens. Blunt and Casey to receive AACI awards

The 2017 AACI Distinguished Scientist Award will be presented to Carl June.

Sens. Roy Blunt (R-MO) and Bob Casey (D-PA) will receive the 2017 AACI Public Service Award at the Association of American Cancer Institutes’ annual meeting, Oct. 15–17, in Washington.

June is director of translational research at the Abramson Cancer Center of the University of Pennsylvania, director of the Parker Institute for Cancer Immunotherapy and the Center for Cellular Immunotherapies, and Richard W. Vague Professor in immunotherapy, department of pathology and laboratory medicine, Perelman School of Medicine at the University of Pennsylvania.

In 2011, June’s research team published findings which represented the first successful and sustained demonstration of the use of gene transfer therapy to treat cancer. On Oct. 16, he will deliver a talk on his ongoing work and the implications of the FDA’s recent approval of gene transfer therapy to treat cancer.

Blunt is chairman of the Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies. Casey is a member of the Senate Committee on Health, Education, Labor, and Pensions.

 

NCCN Radiation Therapy Compendium provides recommendations for 41 disease sites

NCCN announced the release of the Radiation Therapy Compendium that includes information designed to support clinical decision-making around the use of radiation therapy in patients with cancer.

The content is based directly on the NCCN Clinical Practice Guidelines in Oncology, and compiles every reference to radiation therapy across the 41 Guidelines referencing RT.

The NCCN Radiation Therapy Compendium includes a full complement of radiation therapy recommendations found in the current NCCN Guidelines, including … Continue reading Carl June, Sens. Blunt and Casey to receive AACI awards

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.